Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm

Author(s):
Omid MoradiOmid Moradi1,*, Seyed pouzhia ShojaeiSeyed pouzhia Shojaei2, Mehran KouchekMehran KouchekMehran Kouchek ORCID2, MirMohammad MiriMirMohammad Miri2, Sara SalarianSara SalarianSara Salarian ORCID2, Mohammad SistanizadMohammad SistanizadMohammad Sistanizad ORCID1
1Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2Critical Care Medicine Ward, Anesthesiology Department, Imam Hossein (A.S.) Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Journal of Cellular & Molecular Anesthesia:Vol. 5, issue 3; e150187
Published online:Jul 23, 2020
Article type:Letter to the Editor
How to Cite:Moradi O, Shojaei SP, Kouchek M, Miri M, Salarian S, et al. Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm. J Cell Mol Anesth. 2020;5(3):e150187. doi: https://doi.org/10.22037/jcma.v5i3.30630

References

  • 1.
    References are in the PDF file of the article.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles